Tokyo Tape
Sign in
← Ain Holdings

Half-year report · HY

9627.TEDINET S100XAGJ
Period2025-05-01 → 2025-10-31
Filed2025-12-15
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
MetricValuePeriodScopeSource row
Revenue¥299.9bn2025-05-01 → 2025-10-31Cons.Net sales
Revenue¥456.8bn2024-05-01 → 2025-04-30Cons.Net sales (5-year summary)
Revenue¥214.9bn2024-05-01 → 2024-10-31Cons.Net sales
Operating income¥10.5bn2025-05-01 → 2025-10-31Cons.Operating income
Operating income¥5.9bn2024-05-01 → 2024-10-31Cons.Operating income
Ordinary income¥9.9bn2025-05-01 → 2025-10-31Cons.Ordinary income
Ordinary income¥18.1bn2024-05-01 → 2025-04-30Cons.Ordinary income loss (5-year summary)
Ordinary income¥6.3bn2024-05-01 → 2024-10-31Cons.Ordinary income
Profit before tax¥9.6bn2025-05-01 → 2025-10-31Cons.Income before income taxes
Profit before tax¥6.7bn2024-05-01 → 2024-10-31Cons.Income before income taxes
Net income (owners)¥4.5bn2025-05-01 → 2025-10-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥9.3bn2024-05-01 → 2025-04-30Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥3.2bn2024-05-01 → 2024-10-31Cons.Profit loss attributable to owners of parent
Net income¥4.5bn2025-05-01 → 2025-10-31Cons.Profit loss
Net income¥3.2bn2024-05-01 → 2024-10-31Cons.Profit loss
Total assets¥514.6bnat 2025-10-31Cons.Assets
Total assets¥311.9bnat 2025-04-30Cons.Assets
Total assets¥296.0bnat 2024-10-31Cons.Total assets (5-year summary)
Total liabilities¥369.1bnat 2025-10-31Cons.Liabilities
Total liabilities¥169.3bnat 2025-04-30Cons.Liabilities
Net assets / equity¥145.5bnat 2025-10-31Cons.Net assets
Net assets / equity¥142.6bnat 2025-04-30Cons.Net assets
Net assets / equity¥136.1bnat 2024-10-31Cons.Net assets (5-year summary)
Cash and deposits¥53.1bnat 2025-10-31Cons.Cash and deposits
Cash and deposits¥26.9bnat 2025-04-30Cons.Cash and deposits
Cash & equivalents¥52.8bnat 2025-10-31Cons.Cash and cash equivalents
Cash & equivalents¥26.7bnat 2025-04-30Cons.Cash and cash equivalents
Cash & equivalents¥27.2bnat 2024-10-31Cons.Cash and cash equivalents
Cash & equivalents¥48.4bnat 2024-04-30vCons.Cash and cash equivalents
Operating cash flow¥1.2bn2025-05-01 → 2025-10-31Cons.Net cash provided by used in operating activities
Operating cash flow¥23.1bn2024-05-01 → 2025-04-30Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥12.7bn2024-05-01 → 2024-10-31Cons.Net cash provided by used in operating activities
Investing cash flow−¥53.2bn2025-05-01 → 2025-10-31Cons.Net cash provided by used in investment activities
Investing cash flow−¥65.9bn2024-05-01 → 2025-04-30Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥54.0bn2024-05-01 → 2024-10-31Cons.Net cash provided by used in investment activities
Financing cash flow¥78.2bn2025-05-01 → 2025-10-31Cons.Net cash provided by used in financing activities
Financing cash flow¥21.1bn2024-05-01 → 2025-04-30Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow¥20.1bn2024-05-01 → 2024-10-31Cons.Net cash provided by used in financing activities
EPS (basic)¥128.052025-05-01 → 2025-10-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥264.322024-05-01 → 2025-04-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥91.752024-05-01 → 2024-10-31Cons.Basic earnings loss per share (5-year summary)
Equity ratio28.2%at 2025-10-31Cons.Equity to asset ratio (5-year summary)
Equity ratio45.7%at 2025-04-30Cons.Equity to asset ratio (5-year summary)
Equity ratio46.0%at 2024-10-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 34
SegmentItemPeriodValue
Otherother segmentsrevenue2025-05-01 → 2025-10-31¥5.7bn
Otherother segmentsrevenue external2025-05-01 → 2025-10-31¥5.5bn
Otherother segmentsrevenue intersegment2025-05-01 → 2025-10-31¥134m
Otherother segmentssegment ordinary income2025-05-01 → 2025-10-31¥14m
Reconciling Itemsreconcilingrevenue2025-05-01 → 2025-10-31−¥134m
Reconciling Itemsreconcilingrevenue intersegment2025-05-01 → 2025-10-31−¥134m
Reconciling Itemsreconcilingsegment ordinary income2025-05-01 → 2025-10-31−¥6.5bn
Dispensing Pharmacyreportable segmentrevenue2025-05-01 → 2025-10-31¥254.7bn
Dispensing Pharmacyreportable segmentrevenue external2025-05-01 → 2025-10-31¥254.7bn
Dispensing Pharmacyreportable segmentsegment ordinary income2025-05-01 → 2025-10-31¥12.8bn
Drug And Cosmetic Storereportable segmentrevenue2025-05-01 → 2025-10-31¥39.6bn
Drug And Cosmetic Storereportable segmentrevenue external2025-05-01 → 2025-10-31¥39.6bn
Drug And Cosmetic Storereportable segmentsegment ordinary income2025-05-01 → 2025-10-31¥3.5bn
—segment totalrevenue2025-05-01 → 2025-10-31¥300.0bn
—segment totalrevenue external2025-05-01 → 2025-10-31¥299.9bn
—segment totalrevenue intersegment2025-05-01 → 2025-10-31¥134m
—segment totalsegment ordinary income2025-05-01 → 2025-10-31¥16.4bn
Otherother segmentsrevenue2024-05-01 → 2024-10-31¥5.6bn
Otherother segmentsrevenue external2024-05-01 → 2024-10-31¥5.5bn
Otherother segmentsrevenue intersegment2024-05-01 → 2024-10-31¥24m
Otherother segmentssegment ordinary income2024-05-01 → 2024-10-31−¥15m
Reconciling Itemsreconcilingrevenue2024-05-01 → 2024-10-31−¥24m
Reconciling Itemsreconcilingrevenue intersegment2024-05-01 → 2024-10-31−¥24m
Reconciling Itemsreconcilingsegment ordinary income2024-05-01 → 2024-10-31−¥5.0bn
Dispensing Pharmacyreportable segmentrevenue2024-05-01 → 2024-10-31¥186.4bn
Dispensing Pharmacyreportable segmentrevenue external2024-05-01 → 2024-10-31¥186.4bn
Dispensing Pharmacyreportable segmentsegment ordinary income2024-05-01 → 2024-10-31¥9.6bn
Drug And Cosmetic Storereportable segmentrevenue2024-05-01 → 2024-10-31¥22.9bn
Drug And Cosmetic Storereportable segmentrevenue external2024-05-01 → 2024-10-31¥22.9bn
Drug And Cosmetic Storereportable segmentsegment ordinary income2024-05-01 → 2024-10-31¥1.7bn
—segment totalrevenue2024-05-01 → 2024-10-31¥214.9bn
—segment totalrevenue external2024-05-01 → 2024-10-31¥214.9bn
—segment totalrevenue intersegment2024-05-01 → 2024-10-31¥24m
—segment totalsegment ordinary income2024-05-01 → 2024-10-31¥11.3bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 581
ItemContextValueUnit
Cash and cash equivalentsPrior1InterimInstant27199000000JPY
Cash and cash equivalentsInterimInstant52849000000JPY
Advertising expenses sgaPrior1InterimDuration1169000000JPY
Advertising expenses sgaInterimDuration1383000000JPY
Directors compensations sgaPrior1InterimDuration242000000JPY
Directors compensations sgaInterimDuration326000000JPY
Salaries allowances and bonuses sgaPrior1InterimDuration5283000000JPY
Salaries allowances and bonuses sgaInterimDuration7348000000JPY
Legal and employee benefits expenses sgaPrior1InterimDuration1612000000JPY
Legal and employee benefits expenses sgaInterimDuration2856000000JPY
Correspondence and transportation expenses sgaPrior1InterimDuration678000000JPY
Correspondence and transportation expenses sgaInterimDuration1092000000JPY
Rents sgaPrior1InterimDuration3392000000JPY
Rents sgaInterimDuration5756000000JPY
Depreciation sgaPrior1InterimDuration1247000000JPY
Depreciation sgaInterimDuration1941000000JPY
Amortization of goodwill sgaPrior1InterimDuration2573000000JPY
Amortization of goodwill sgaInterimDuration4792000000JPY
Revenues from external customersPrior1InterimDuration_jpcrp040300-ssr_E04896-000DispensingPharmacyReportableSegmentsMember186439000000JPY
Revenues from external customersPrior1InterimDuration_jpcrp040300-ssr_E04896-000DrugAndCosmeticStoreReportableSegmentsMember22885000000JPY
Revenues from external customersPrior1InterimDuration_OtherReportableSegmentsMember5535000000JPY
Revenues from external customersPrior1InterimDuration_ReportableSegmentsMember214860000000JPY
Revenues from external customersPrior1InterimDuration_ReconcilingItemsMember－JPY
Revenues from external customersPrior1InterimDuration214860000000JPY
Transactions with other segmentsPrior1InterimDuration_jpcrp040300-ssr_E04896-000DispensingPharmacyReportableSegmentsMember－JPY
Transactions with other segmentsPrior1InterimDuration_jpcrp040300-ssr_E04896-000DrugAndCosmeticStoreReportableSegmentsMember－JPY
Transactions with other segmentsPrior1InterimDuration_OtherReportableSegmentsMember24000000JPY
Transactions with other segmentsPrior1InterimDuration_ReportableSegmentsMember24000000JPY
Transactions with other segmentsPrior1InterimDuration_ReconcilingItemsMember-24000000JPY
Transactions with other segmentsPrior1InterimDuration－JPY
Net salesPrior1InterimDuration_jpcrp040300-ssr_E04896-000DispensingPharmacyReportableSegmentsMember186439000000JPY
Net salesPrior1InterimDuration_jpcrp040300-ssr_E04896-000DrugAndCosmeticStoreReportableSegmentsMember22885000000JPY
Net salesPrior1InterimDuration_OtherReportableSegmentsMember5560000000JPY
Net salesPrior1InterimDuration_ReportableSegmentsMember214885000000JPY
Net salesPrior1InterimDuration_ReconcilingItemsMember-24000000JPY
Net salesPrior1InterimDuration214860000000JPY
Ordinary incomePrior1InterimDuration_jpcrp040300-ssr_E04896-000DispensingPharmacyReportableSegmentsMember9648000000JPY
Ordinary incomePrior1InterimDuration_jpcrp040300-ssr_E04896-000DrugAndCosmeticStoreReportableSegmentsMember1694000000JPY
Ordinary incomePrior1InterimDuration_OtherReportableSegmentsMember-15000000JPY
Ordinary incomePrior1InterimDuration_ReportableSegmentsMember11326000000JPY
Ordinary incomePrior1InterimDuration_ReconcilingItemsMember-4988000000JPY
Ordinary incomePrior1InterimDuration6338000000JPY
Revenues from external customersInterimDuration_jpcrp040300-ssr_E04896-000DispensingPharmacyReportableSegmentsMember254739000000JPY
Revenues from external customersInterimDuration_jpcrp040300-ssr_E04896-000DrugAndCosmeticStoreReportableSegmentsMember39568000000JPY
Revenues from external customersInterimDuration_OtherReportableSegmentsMember5549000000JPY
Revenues from external customersInterimDuration_ReportableSegmentsMember299857000000JPY
Revenues from external customersInterimDuration_ReconcilingItemsMember－JPY
Revenues from external customersInterimDuration299857000000JPY
Transactions with other segmentsInterimDuration_jpcrp040300-ssr_E04896-000DispensingPharmacyReportableSegmentsMember－JPY
Transactions with other segmentsInterimDuration_jpcrp040300-ssr_E04896-000DrugAndCosmeticStoreReportableSegmentsMember－JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2025-04-30pass rounding
balance sheet identityconsolidated 2025-10-31pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2025-04-30pass
statement vs summary · net assetsconsolidated 2025-10-31pass
statement vs summary · net income attributable to parentconsolidated 2024-05-01/2024-10-31pass
statement vs summary · net income attributable to parentconsolidated 2025-05-01/2025-10-31pass
statement vs summary · operating cash flowconsolidated 2024-05-01/2024-10-31pass
statement vs summary · operating cash flowconsolidated 2025-05-01/2025-10-31pass
statement vs summary · revenueconsolidated 2024-05-01/2024-10-31pass
statement vs summary · revenueconsolidated 2025-05-01/2025-10-31pass
statement vs summary · total assetsconsolidated 2025-04-30pass
statement vs summary · total assetsconsolidated 2025-10-31pass